EDGE-TO-EDGE REPAIR (TEER)
MitraClip™ is the first minimally invasive TEER* therapy that delivers a life-changing treatment option for selected patients with Primary Mitral Regurgitation (PMR) or Secondary Mitral Regurgitation (SMR) who would otherwise go untreated.1,2 MitraClip™ is the standard of care in TMVr built on the only proven mitral valve therapy with over 20 years of experience, an extensive body of clinical evidence, and more than 150,000 patients treated worldwide.3
MitraClip™ delivers uncompromising performance in TEER and sets the standard in clinical outcomes. With each generation of MitraClip™, Abbott remains at the forefront of therapeutic expertise, partnering with heart teams to help selected patients with Mitral Regurgitation (MR) reclaim their lives.
FIND OUT MORE ABOUT:
ESC 2023 HF Satellite Symposium
EACVI Summit 2023: Congress symposium
EuroPCR 2023: Mitral regurgitation
Echo course mitral TEER – cases
Echo course mitral TEER – procedural approach
Echo course mitral TEER – patient selection
EuroPCR 2022: Mitral replacement
EuroPCR 2022: Leading clinical evidence
HF 2022: FMR
EACTS 2022: Tendyne™ vs on-pump MVR
*The testimonial does not provide any indication, guide, warranty or guarantee as to the response patients may have to the treatment or effectiveness of the product or therapy in discussion. Opinions about the treatment discussed can and do vary and are specific to the individual’s experience and might not be representative of others.
**Tests performed by and data on file at Abbott.
- MitraClip™ G4 System Instructions for Use.
- Lim DS, Reynolds MR, Feldman T, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after the transcatheter mitral valve repair. J Am Coll Cardiol. 2014;64(2):182–192. doi.org/10.1016/j.jacc.2013.10.021.
- Data on file at Abbott.
- Heidenreich PA, Bozkurt B, Allen LA, et al. “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association. Joint Committee on Clinical Practice Guidelines.” J Am Coll Cardiol. 2022;28(5):E1–E167. doi.org/10.1016/j.cardfail.2022.02.010.
- Mirabel M, Lung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–1365. doi.org/10.1093/eurheartj/ehm001.
- Cioffi G, Tarantini L, De Feo S, et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail. 2005;7(7):1112–1117. doi.org/10.1016/j.ejheart.2005.01.016.
- Rottbauer WD. Contemporary Clinical Outcomes with MitraClip™ (NTR/XTR) System: Core-lab Echo Results from +1000 Patient the Global EXPAND Study. Data presented at PCR 2020.
- Maisano F. Clip Selection Strategy and Outcomes with MitraClip™ (NTR/XTR): Evidence-Based Recommendations from the Global EXPAND Study. Data presented at PCR 2020.
- Rodriguez E. Contemporary Outcomes with the MitraClip™ G4 System: Preliminary Results based on the EXPAND G4 Study. Data presented at TCT 2021.
- Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Scientific Document Group, 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J.2022;43(7):561–632, doi.org/10.1093/eurheartj/ehab395.
- Yeo KK, Tan JWC, Muller DW, et al. Asian Pacific Society of Cardiology Consensus Recommendations on the Use of MitraClip for Mitral Regurgitation. Eur Cardiol. 2021;16:e25. doi.org/10.15420/ecr.2021.01.
- McDonagh TA, Metra M, Adamo M, et al., ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J.2012; 42(36):3599–3726, doi.org/10.1093/eurheartj/ehab368.